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(GPI). Joint pain is frequently reported as the most egregious symptom.
However, though inﬂammation contributes to pain in RA, it may not
be the only factor. For some patients, pain does not improve despite
treatment with anti-inﬂammatory disease-modifying anti-rheumatic
drugs.
Systemic injection of type II collagen and GPI antibodies to mice induces
transient arthritis-like symptoms and joint pathology that resembles
human RA. While these models, called collagen-antibody induced
arthritis (CAIA) and K/BxN serum transfer arthritis (K/BxN) respectively,
are commonly used in the rheumatology ﬁeld, they have prior to our
work not been evaluated as models of arthritis-induced pain. Both
models generate pronounced pain-like behaviors such as mechanical
allodynia and reduced locomotor activity. Strikingly, the pain-like
behaviors occur not only during the inﬂammatory phase but outlast
the inﬂammation by at least four weeks. Of note, cyclooxygenase and
TNF inhibitors only have anti-nociceptive effect during the inﬂammatory
phase, while drugs like gabapentin reduce the hypersensitivity in
both phases, and pentoxifylline only reduces pain behavior during
the late phase, indicating that inﬂammatory and “post-inﬂammatory”
nociception are maintained through different mechanisms in these
models. This, taken together with the observation that ATF-3, a common
marker of nerve injury, is induced in dorsal root ganglia and that spinal
glia are activated in the late phase suggest that joint inﬂammation may
have a nerve damaging effect and that the persistent hypersensitivity
is driven at least in part by spinal sensitization. Interestingly, our
pharmacological and histological ﬁndings from the late phase of the CAIA
and K/BxN models show similarities with published data from animal
models of OA. Hence, our work suggest that a transient episode of joint
inﬂammation and/or joint damage may lead to long-term changes the
sensory system and it is possible that the late phase of the CAIA and
K/BxN models may be useful also for deciphering not only RA, but also
OA pain mechanisms. The aim of this presentation is to give a brief
overview of the physiology of OA pain, introduce the CAIA and K/BxN
models as new models of arthritis-induced pain and discuss similarities
and differences between RA and OA-induced pain from an experimental
point of view.
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GENETICS AND THE FUNCTIONAL ANALYSIS OF OA SUSCEPTIBILITY
LOCI
J. Loughlin. Newcastle Univ., Newcastle upon Tyne, United Kingdom
Genome-wide association scans are beginning to uncover novel
susceptibility loci for OA and these scans, combined with data from
some of the candidate gene based studies, are slowly enlightening our
understanding of the molecular genetic basis of this common arthritis.
Some of the discoveries are to genes whose proteins are known to have
roles in joint formation and maintenance whereas others are to genes
whose encoded proteins have less explicable roles in the articulating
joint. To exploit the genetic data for future use there is a need to
understand the impact OA susceptibility alleles are having on gene and
protein function and to understand how these alleles are themselves
modulated by, amongst other things, epigenetic regulation. This talk will
focus on the genetic and functional analysis of OA susceptibility and
present data on how our understanding of OA susceptibility is enhanced
when we advance from the purely genetic discoveries.
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ADHERENCE TO BEST PRACTICE IN THE CONSERVATIVE
MANAGEMENT OF OSTEOARTHRITIS
N.E. Foster. Keele Univ., Keele, United Kingdom
Peripheral joint osteoarthritis is a major cause of pain and functional
limitations in older adults in the community. Non-pharmacological
interventions play a key role in the holistic management of patients
with osteoarthritis. Advice and education about self-management,
exercise and physical activity, as well as weight loss, for example,
are consistent recommendations for clinical practice in national and
international guidelines [1,2]. These guidelines target patients, the
public and all health professionals involved in the care of this patient
population, including rheumatologists, family doctors, physical therapists
and others. This presentation will summarise best practice for patients
with osteoarthritis with a particular focus on non-pharmacological
interventions and examine the gap between best practice and current
practice, incorporating evidence about this gap from the perspectives of
patients and health care professionals. There are known barriers to the
adoption of best practice and whilst the key barriers will be discussed,
the presentation will focus on ways to improve the uptake of non-
pharmacological interventions in order to optimise patients’ outcomes.
This will include consideration of the potential drivers for change towards
adherence to best practice.
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INTRA-ARTICULAR INJECTION OF PURIFIED MESENCHYMAL STEM
CELLS FROM C57BL/6 OR MRL/MPJ “SUPERHEALER” MICE PREVENTS
POSTTRAUMATIC ARTHRITIS
B.O. Diekman, C-L. Wu, C.S. Louer, B.D. Furman, J.L. Huebner, V.B. Kraus,
S.A. Olson, F. Guilak. Duke Univ., Durham, NC, USA
Joint injury dramatically enhances the onset of osteoarthritis (OA) and
is responsible for an estimated 12% of OA. In particular, intra-articular
fracture is one of the greatest risk factors for the development of post-
traumatic arthritis (PTA); however, there are no therapeutic options
available that can alter the course of joint disease in this case. Using a
mouse model of PTA, the delivery of mesenchymal stem cells (MSCs)
to the joint was investigated to test the hypothesis that MSCs are
able to prevent PTA by altering the balance of inﬂammation and
regeneration after injury. Additionally, MSCs from c57BL/6 (B6) and
MRL/MpJ (MRL) mouse strains were compared, as MRL “superhealer”
mice have shown exceptional regenerative abilities. A pure population of
MSCs was prospectively isolated from bones using cell surface markers
(CD45-TER119-PDGFRa+Sca-1+). B6 MSCs expanded greater than 100,000
fold in three weeks when cultured at 2% oxygen and displayed greater
adipogenic, osteogenic, and chondrogenic differentiation as compared
to MRL MSCs. Mice receiving only a control saline injection after
fracture demonstrated signiﬁcant increase in cartilage degeneration after
8 weeks, but the delivery of 10,000 B6 or MRL MSCs to the joint was able
to prevent the development of PTA. MSC injection did not reduce the
degree of synovial inﬂammation but did show trends towards increasing
the bone volume during repair. This study provides evidence that adult
stem cell therapy can help prevent the development of PTA after fracture
and has implications for possible clinical interventions after joint injury
before evidence of signiﬁcant OA.
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HIP SHAPE AND OA: PREVENTION AND MANAGEMENT
Y-J. Kim. Children’s Hosp. Boston, Boston, MA, USA
Osteoarthritis of the hip is often due to underlying structural
abnormalities such as acetabular dysplasia, acetabular protrusio,
acetabular retroversion, or pistol grip deformity of the proximal femur.
Acetabular dysplasia is a shallowness of the acetabulum that leads to hip
instability and increased loading at the acetabular rim and osteoarthritis.
Acetabular protrusio, retroversion with or without a pistol grip deformity
of the proximal femur causes mechanical impingement, which may lead
to osteoarthritis. These mechanical causes of osteoarthritis were once
thought to be due to bony remodeling in response to osteoarthritis.
However, new evidence suggests that often these deformities preceed the
development of osteophyte and bony remodeling. Furthermore, some of
these hip deformities are highly prevalent in the general population and
may be an important risk factor for the development of osteoarthritis.
This talk will review the current available evidence that suggests these
structural variations are important as a cause of premature osteoarthritis,
as well as remaining controversies and needed future research. At
